Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal
Status:
Not yet recruiting
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
This study will explore the effectiveness and tolerability of Cannabidiol (CBD) in the
treatment of alcohol withdrawal symptoms in an inpatient setting, in a double-blind
randomised placebo-controlled trial.
Phase:
Early Phase 1
Details
Lead Sponsor:
South West Sydney Local Health District
Collaborators:
South Eastern Sydney Local Health District University of Sydney